Cinacalcet for the Treatment of Humoral Hypercalcemia of Malignancy: An Introductory Case Report with a Pathophysiologic and Therapeutic Review

Hypercalcemia is an ominous development in the course of malignancy associated with a mean survival of only several months. A majority of cases of hypercalcemia are related to humoral hypercalcemia of malignancy (HHM), where hypercalcemia is caused by increased levels of circulating parathyroid horm...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheehan, Michael, Tanimu, Sabo, Tanimu, Yusuf, Engel, Jessica, Onitilo, Adedayo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154241/
https://www.ncbi.nlm.nih.gov/pubmed/32308599
http://dx.doi.org/10.1159/000506100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154241/
https://www.ncbi.nlm.nih.gov/pubmed/32308599
http://dx.doi.org/10.1159/000506100

Ejemplares similares